Skip to main content
Abattis Bioceuticals Corp. logo

Abattis Bioceuticals Corp. — Investor Relations & Filings

Ticker · ATTBF ISIN · CA00258G1037 LEI · 5493000GEXZZJ997G829 CSE Professional, scientific and technical activities
Filings indexed 15 across all filing types
Latest filing 2021-03-20 Regulatory Filings
Country CA Canada
Listing CSE ATTBF

About Abattis Bioceuticals Corp.

https://www.abattis.com

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company. Its core business involves aggregating, integrating, and investing in cannabis technologies and related biotechnology services. The company is engaged in the development and licensing of natural health products and health solutions, often focusing on applications for chronic illnesses in human and animal health sectors, particularly within the framework of the legal cannabis industry.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2021-03-20 English
News release - English.pdf
Regulatory Filings
2020-09-01 English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf
Regulatory Filings
2020-07-28 English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf
Regulatory Filings
2020-07-28 English
Interim MD&A (amended) - English.pdf
Regulatory Filings
2020-07-28 English
Cover letter.pdf
Regulatory Filings
2020-07-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.